AMAmanda Fernandes Klajn Maycá

Amanda Fernandes Klajn Maycá

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amanda Fernandes Klajn Maycá has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Changes in Clinical Outcomes and Peripheral Cytokines during Duloxetine Add‐on Therapy in Parkinson's Disease

    by Juliana Oliveira Freitas Silveira, Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Amanda Fernandes Klajn, Fernanda Rossatto Temp, Bruna Amanda Girardi, Marta Maria Medeiros Frescura Duarte, Thiago Duarte, Paulo Gilberto Medeiros Jauris, Carlos Fernando Mello

    Background: Neuroinflammation is implicated in Parkinson's disease (PD), and antidepressants may have anti‐inflammatory and motor benefits. The effects of duloxetine on inflammatory biomarkers and clinical outcomes in PD remain unclear. Objectives: To assess changes in motor symptoms, quality of life, and serum cytokines during add‐on duloxetine treatment in PD. Methods: Seventeen patients with PD without other chronic inflammatory diseases received add‐on duloxetine for 8 weeks in an open‐label, uncontrolled trial. Clinical outcomes included Unified Parkinson's Disease Rating Scale (UPDRS), modified Hoehn and Yahr (HY), and Parkinson's Disease Questionnaire‐39 (PDQ‐39) scores. Serum TNF‐α, IL‐1β, IL‐6, and IL‐10 levels were measured at baseline and follow‐up. Results: UPDRS, activities of daily living, and PDQ‐39 scores decreased during treatment. Ten patients achieved ≥5‐point UPDRS reductions. TNF‐α, IL‐1β, and IL‐6 decreased, whereas IL‐10 increased after treatment. Conclusions: Add‐on duloxetine was associated with changes in clinical outcomes and inflammatory markers in patients with PD.

  • Open Access

    Diagnostic challenges in dengue encephalitis: subtle imaging findings and initially negative laboratory test in a kidney transplant recipient

    by Juan Sebastián Sánchez León, Vanessa Dantas de Andrade, Amanda Fernandes Klajn Maycá, Carolina Matte Dagostini, Marcela Nataly Parra Alvarez, Marlise Ribeiro de Castro

    Dengue encephalitis is an uncommon neurological complication of dengue virus infection. In immunocompromised patients, such as solid organ transplant recipients, the clinical presentation may be atypical and nonspecific, posing significant diagnostic and therapeutic challenges. We report a clinical case and use it as a framework to discuss key considerations for suspicion of dengue encephalitis. Topics include optimal timing for clinical suspicion, essential differential diagnoses, and the most appropriate diagnostic strategies. Emphasis is placed on the correct interpretation of cerebrospinal fluid findings and recognition of subtle brain magnetic resonance imaging changes that may support the diagnosis. The discussion also reviews current evidence on dengue encephalitis in immunocompromised populations, highlighting implications for timely diagnosis and management in this vulnerable group.